Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Oral Anti-Cancer Drugs

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
OBJECTIVES To review literature characteristics, describe methodological trends, and assess the reporting quality of the economic… Expand
Is this relevant?
2017
2017
PURPOSE During the last decade, many oral anticancer drugs (OAcDs) have been marketed, providing interesting but potentially… Expand
  • table 3
  • figure 1
  • table 4
Is this relevant?
Review
2016
Review
2016
As the use of oral chemotherapy continues to rise, new approaches are needed to ensure patient safety. To help address this issue… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2016
Review
2016
ABSTRACT Many studies have demonstrated that non-adherence to oral anticancer drugs (OACDs) has challenged treatment efficacy… Expand
Is this relevant?
Review
2016
Review
2016
Background: Around 14.1 million new cancer cases and 8.2 million deaths caused by cancer were reported in 2012, expected to rise… Expand
Is this relevant?
2012
2012
4622 Background: Patient adherence to oral therapy is a critical issue in cancer treatment. The aim of this study is to… Expand
Is this relevant?